191 related articles for article (PubMed ID: 26722757)
41. Targeting Influenza A Virus RNA Promoter.
Bottini A; De SK; Wu B; Tang C; Varani G; Pellecchia M
Chem Biol Drug Des; 2015 Oct; 86(4):663-73. PubMed ID: 25676805
[TBL] [Abstract][Full Text] [Related]
42. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
Yeh JY; Coumar MS; Horng JT; Shiao HY; Kuo FM; Lee HL; Chen IC; Chang CW; Tang WF; Tseng SN; Chen CJ; Shih SR; Hsu JT; Liao CC; Chao YS; Hsieh HP
J Med Chem; 2010 Feb; 53(4):1519-33. PubMed ID: 20092255
[TBL] [Abstract][Full Text] [Related]
43. Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
Kolocouris A; Tzitzoglaki C; Johnson FB; Zell R; Wright AK; Cross TA; Tietjen I; Fedida D; Busath DD
J Med Chem; 2014 Jun; 57(11):4629-39. PubMed ID: 24793875
[TBL] [Abstract][Full Text] [Related]
44. Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
Bereczki I; Kicsák M; Dobray L; Borbás A; Batta G; Kéki S; Nikodém ÉN; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3251-4. PubMed ID: 24974341
[TBL] [Abstract][Full Text] [Related]
45. Camphor-based symmetric diimines as inhibitors of influenza virus reproduction.
Sokolova AS; Yarovaya OC; Korchagina DV; Zarubaev VV; Tretiak TS; Anfimov PM; Kiselev OI; Salakhutdinov NF
Bioorg Med Chem; 2014 Apr; 22(7):2141-8. PubMed ID: 24631360
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.
Yu Y; Tang Q; Xu Z; Li S; Jin M; Zhao Z; Dong C; Wu S; Zhou HB
Eur J Med Chem; 2018 Nov; 159():206-216. PubMed ID: 30292897
[TBL] [Abstract][Full Text] [Related]
48. How to overcome resistance of influenza A viruses against adamantane derivatives.
Scholtissek C; Quack G; Klenk HD; Webster RG
Antiviral Res; 1998 Feb; 37(2):83-95. PubMed ID: 9588841
[TBL] [Abstract][Full Text] [Related]
49. Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
Wang J; Ma C; Wang J; Jo H; Canturk B; Fiorin G; Pinto LH; Lamb RA; Klein ML; DeGrado WF
J Med Chem; 2013 Apr; 56(7):2804-12. PubMed ID: 23437766
[TBL] [Abstract][Full Text] [Related]
50. Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
Tu Q; Pinto LH; Luo G; Shaughnessy MA; Mullaney D; Kurtz S; Krystal M; Lamb RA
J Virol; 1996 Jul; 70(7):4246-52. PubMed ID: 8676445
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
Su Y; Meng L; Sun J; Li W; Shao L; Chen K; Zhou D; Yang F; Yu F
Eur J Med Chem; 2019 Nov; 182():111622. PubMed ID: 31425909
[TBL] [Abstract][Full Text] [Related]
52. Novel daidzein analogs and their in vitro anti-influenza activities.
Chung ST; Huang YT; Hsiung HY; Huang WH; Yao CW; Lee AR
Chem Biodivers; 2015 Apr; 12(4):685-96. PubMed ID: 25879510
[TBL] [Abstract][Full Text] [Related]
53. Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus.
Kessler U; Castagnolo D; Pagano M; Deodato D; Bernardini M; Pilger B; Ranadheera C; Botta M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5575-7. PubMed ID: 24012120
[TBL] [Abstract][Full Text] [Related]
54. Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection.
Yu Y; Qin HJ; Shi XX; Song JQ; Zhou JP; Yu P; Fan ZC; Zhong M; Yang Y
Eur J Med Chem; 2020 Aug; 199():112357. PubMed ID: 32428793
[TBL] [Abstract][Full Text] [Related]
55. Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.
Duque MD; Ma C; Torres E; Wang J; Naesens L; Juárez-Jiménez J; Camps P; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
J Med Chem; 2011 Apr; 54(8):2646-57. PubMed ID: 21466220
[TBL] [Abstract][Full Text] [Related]
56. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
[TBL] [Abstract][Full Text] [Related]
57. 1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.
Geisman AN; Valuev-Elliston VT; Ozerov AA; Khandazhinskaya AL; Chizhov AO; Kochetkov SN; Pannecouque C; Naesens L; Seley-Radtke KL; Novikov MS
Bioorg Med Chem; 2016 Jun; 24(11):2476-2485. PubMed ID: 27112451
[TBL] [Abstract][Full Text] [Related]
58. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.
Deng C; Wang X; Wang T; Liu W; Yuan X; Huang Y; Cao S
J Biomol Struct Dyn; 2024 Jul; 42(10):5253-5267. PubMed ID: 37424098
[TBL] [Abstract][Full Text] [Related]
59. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
60. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90.
Lamut A; Gjorgjieva M; Naesens L; Liekens S; Lillsunde KE; Tammela P; Kikelj D; Tomašič T
Bioorg Chem; 2020 May; 98():103733. PubMed ID: 32171985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
